Form 4: Colgate-Palmolive CHRO Receives Equity Grants
Insider Transaction Report
Colgate-Palmolive's Chief Human Resources Officer, Sally Massey, was granted 3,450 restricted stock units and 23,888 stock options as part of the company's incentive compensation plan.
Summary
- Sally Massey, Chief Human Resources Officer of Colgate-Palmolive Co. (CL), was granted equity awards on September 11, 2025.
- The awards include 3,450 shares of Common Stock as Restricted Stock Units (RSUs), which vest in equal one-third installments on the first, second, and third anniversaries of the grant date.
- Additionally, 23,888 stock options were granted with an exercise price of $84.06, becoming exercisable in equal annual installments over three years, beginning on the first anniversary of the September 11, 2025 grant date, and expiring on September 11, 2033.
- Following these transactions, Ms. Massey directly holds 16,062 shares of Common Stock and 23,888 stock options, and indirectly holds 8,004 shares through the Issuer's 401(k) Plan Trustee.
Sentiment
Score: 7
Explanation: The grant of equity awards to a key executive is generally a positive signal, indicating commitment to executive retention and performance alignment with shareholder interests. It's a routine compensation event, not a major market mover, hence a moderate positive score.
Positives
- The grant of 3,450 Restricted Stock Units (RSUs) aligns the executive's interests with long-term shareholder value creation.
- The award of 23,888 stock options provides an incentive for the Chief Human Resources Officer to contribute to the company's stock price appreciation.
- Equity compensation is a standard practice to attract and retain key executive talent.
Future Outlook
The future outlook for the Chief Human Resources Officer's equity holdings is tied to the vesting schedule of the Restricted Stock Units over three years and the exercisability of the stock options over three years, with an expiration date in 2033. These awards are designed to incentivize long-term performance.
Industry Context
The granting of equity awards, including restricted stock units and stock options, to senior executives like the Chief Human Resources Officer, is a common practice across the consumer staples industry. This compensation structure aims to align executive incentives with shareholder interests and promote long-term retention and performance within competitive talent markets.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation | The equity awards were granted under the issuer's incentive compensation plan, reflecting the company's established executive remuneration policies. | 09/11/2025 | Reinforces alignment of executive incentives with long-term company performance and shareholder value. |
Stakeholder Impact
- Shareholders: Potential positive impact through increased alignment of executive interests with long-term company performance and stock appreciation.
- Employees: May signal a stable and competitive compensation structure for senior leadership.
Next Steps
- Vesting of 3,450 Restricted Stock Units in equal 1/3 installments on the first, second, and third anniversaries of September 11, 2025.
- Stock options for 23,888 shares will become exercisable in equal annual installments over three years, starting on the first anniversary of September 11, 2025.
Key Dates
| Date | Description |
|---|---|
| 09/11/2025 | Grant date for Restricted Stock Units and Stock Options. |
| 09/11/2026 | First vesting installment for RSUs and first exercisability installment for stock options. |
| 09/11/2027 | Second vesting installment for RSUs and second exercisability installment for stock options. |
| 09/11/2028 | Third vesting installment for RSUs and third exercisability installment for stock options. |
| 09/11/2033 | Expiration date for stock options. |
| 09/12/2025 | Date Form 4 was signed by Attorney-in-Fact. |
Keywords
Colgate-Palmolive, CL, Sally Massey, Chief Human Resources Officer, Executive Compensation, Restricted Stock Units, Stock Options, Insider Transaction, Equity Grant, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.